|
Market Closed -
Toronto S.E.
15:51:20 2026-09-10 EDT
|
5-day change | 1st Jan Change | ||
| 27.49 CAD | -0.83% |
|
-1.68% | +6.96% |
| 09-03 | Hutchmed Enters Licensing Agreement With GSK for Cancer Drug | DJ |
| 09-02 | Roche, Treeline Biosciences to Evaluate Combination Therapy for B-cell Lymphomas | MT |
| Market Cap | 276B 340B 293B 251B 470B 32,525B 474B 3,288B 1,265B 16,497B 1,277B 1,250B 52,399B | P/E 2026 * |
18.8x | P/E 2027 * | 16.9x |
|---|---|---|---|---|---|
| Enterprise Value | 287B 354B 304B 261B 489B 33,805B 493B 3,417B 1,315B 17,147B 1,328B 1,299B 54,462B | EV / Sales 2026 * |
4.58x | EV / Sales 2027 * | 4.28x |
| Free-Float |
88.78% | Yield 2026 * |
2.9% | Yield 2027 * | 2.97% |
| Markets | Quality | ||
|---|---|---|---|
Toronto S.E.
| ROG | Delayed | |
Deutsche Boerse AG
| RHO0 | Delayed |
Last Transcript : Roche Holding AG
| 1 day | -0.83% | ||
| 1 week | -1.68% | ||
| Current month | -1.86% | ||
| 1 month | -3.61% | ||
| 3 months | +7.22% | ||
| 6 months | +5.04% | ||
| Current year | +6.96% |
| 1 week | 27.49 |  | 27.9 |
| 1 month | 27.49 | | 29.87 |
| Current year | 23.46 | | 29.87 |
| 1 year | 20.03 | | 29.87 |
| 3 years | 18.42 | | 29.87 |
| 5 years | 18.42 | | 29.87 |
| 10 years | 18.42 | | 29.87 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 51 | 2023-03-14 | |
Alan Hippe
DFI | Director of Finance/CFO | 59 | 2011-06-05 |
| Chief Operating Officer | - | 2025-09-30 |
| Director | Title | Age | Since |
|---|---|---|---|
André Hoffmann
BRD | Director/Board Member | 68 | 1995-12-31 |
Severin Schwan
CHM | Chairman | 59 | 2023-03-14 |
| Director/Board Member | 73 | 2015-03-02 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.83% | -1.68% | - | - | 340B | |
| -0.11% | -3.16% | +48.82% | +91.49% | 1,001B | |
| -0.27% | -4.34% | +51.52% | +65.89% | 642B | |
| +1.63% | -2.00% | +20.49% | +71.12% | 451B | |
| -0.13% | -3.25% | +28.69% | +36.04% | 340B | |
| +0.52% | -13.24% | +10.45% | +27.30% | 263B | |
| +0.07% | -2.03% | -1.62% | +12.00% | 247B | |
| -2.25% | -13.88% | +37.33% | +47.43% | 207B | |
| -2.51% | -5.79% | -18.59% | -58.82% | 197B | |
| -0.58% | -4.24% | +25.65% | +90.54% | 180B | |
| Average | -0.38% | -5.53% | +22.53% | +42.55% | 391.82B | |
| Weighted average by Cap. | -0.09% | -4.65% | +31.74% | +57.51% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 62.65B 77.21B 66.4B 57.07B 107B 7,382B 108B 746B 287B 3,744B 290B 284B 11,892B | 65.46B 80.67B 69.38B 59.63B 111B 7,713B 112B 780B 300B 3,912B 303B 296B 12,426B |
| Net income | 14.5B 17.87B 15.36B 13.21B 24.69B 1,708B 24.91B 173B 66.45B 866B 67.09B 65.62B 2,752B | 16.32B 20.11B 17.29B 14.86B 27.79B 1,923B 28.04B 194B 74.79B 975B 75.51B 73.86B 3,097B |
| Net Debt | 10.87B 13.39B 11.52B 9.9B 18.51B 1,280B 18.68B 129B 49.81B 649B 50.29B 49.19B 2,063B | 4.02B 4.95B 4.26B 3.66B 6.84B 473B 6.91B 47.86B 18.42B 240B 18.6B 18.19B 763B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-10 | $27.49 | -0.83% | 400 |
| 26-09-09 | $27.72 | -0.86% | 2,104 |
| 26-09-02 | $27.96 | +0.94% | 3,704 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ROP Stock
- ROG Stock
Select your edition
All financial news and data tailored to specific country editions
